Loading clinical trials...
Loading clinical trials...
Dental caries is a major public health probleme the result of hard tissue demineralization and oral microbiota changes. Methanogenic archaea, mainly Methanobrevibacter oralis, are associated with various oral problems, including pathologies periodontal. Previous research has not really studied the Archaea in carious lesions, hence the importance of our study. Our study aims to explore their potential role in the the development of caries by analysing their prevalence and their quantification in relation to the carious risk individual. The aim is to improve understanding of the Cavity microbiology to advance management of this pathology in terms of prevention or of treatment. Our team is particularly competent in the field of Archaea, especially in the cultivation of Archaea methanogens since we have a dedicated platform. We also discovered the first human Nanoarchaea, opening up a whole new possible search field.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Asssistance Publique Hopitaux de Marseille
Marseille, France
Start Date
February 19, 2026
Primary Completion Date
February 19, 2027
Completion Date
February 1, 2028
Last Updated
February 23, 2026
200
ESTIMATED participants
saliva sample
OTHER
carious tissue samples
OTHER
Lead Sponsor
Assistance Publique Hopitaux De Marseille
NCT06430957
NCT06944028
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions